World of DTC Marketing

DECEMBER 2, 2021

” So, are we supposed to believe that better images in DTC ads lead to patients asking for an Rx? Ad recall is essential for CPGs, but for prescription drugs, the question that’s missing is “what action did it lead to? Higher numeracy was associated with better gist and verbatim recall.” ” Uh…no.

Food and Drug Administration 185

Food and Drug Administration Side effects FDA Prescription 185

MedCity News

OCTOBER 23, 2022

billion, leading to $13.6 The study found that if certain adults received medically-tailored meals, about 1.6 million hospitalizations would have been avoided, resulting in $38.7 billion saved in healthcare expenditures. Programs to provide these meals would have cost $24.8 billion in net savings, according to the report.

Medical 201

Medical Leads Healthcare Healthcare 201

World of DTC Marketing

JUNE 5, 2021

There is disagreement whether obesity is really considered a disease or a behavioral risk factor, similar to smoking, alcohol, and substance abuse that may lead to disease. Some of the environmental conditions that lead to obesity are physical activity, alcohol consumption, socioeconomic status, parent feeding behavior, and diet.

Government 193

Government Medicine Food Management 193

MedCity News

JUNE 8, 2023

Like many women of my generation, I was labeled as intellectually gifted as a kid and school work was easy, but no one saw the intense sensory challenges of my day to day: struggles with showering, brushing my teeth, lighting, temperature, food textures; the list is endless. This will lead to better patient experiences and outcomes.

Medical 279

Medical Patients Doctors Training 279

World of DTC Marketing

AUGUST 25, 2020

grossly misrepresented data about a therapy,” said Dr. Walid Gellad, who leads the Center for Pharmaceutical Policy and Prescribing at the University of Pittsburgh. While most of the spending is directed at drug pricing I am worried that the money could lead to more political pressure on the FDA to approve drugs.

Food and Drug Administration 188

Food and Drug Administration FDA Ethics Prescription 188

European Pharmaceutical Review

APRIL 25, 2025

Insmed shared that brensocatib is currently under Priority Review with the US Food and Drug Administration (FDA). A target action date is set for 12 August 2025. The post Could investigational drug become first-in-class bronchiectasis therapy? appeared first on European Pharmaceutical Review.

Food and Drug Administration 52

Food and Drug Administration Medicine Consulting Physicians 52

World of DTC Marketing

JANUARY 14, 2022

Anything and everything we could ever want is at our fingertips, from the food we eat to the movies we watch. I often tell people that working in pharma is often frustrated as they are incredibly process-driven and that matrix organizational structures lead to very slow decision-making. We live in an instant gratification world.

Pharma 277

Pharma Recruitment Food Marketing 277

World of DTC Marketing

MARCH 23, 2022

The program was codified into law under the Food and Drug Safety and Innovation Act (FDASIA) in 2012. Accelerated Approval was developed in 1992 in response to the HIV/AIDS crisis and has led to expedited drug and biologic approvals in several disease areas across the FDA.

Patients 200

Patients FDA Doctors Physicians 200

World of DTC Marketing

JUNE 22, 2022

A new feature—a sensor that monitors changes in the heart rate for irregularities that can lead to strokes and heart failure—has just been approved by America’s Food and Drug Administration (FDA). It has come a long way since the Nintendo Wii motion-detecting game console inspired Fitbit’s founders.

Healthcare 227

Healthcare Healthcare Food and Drug Administration FDA 227

World of DTC Marketing

SEPTEMBER 7, 2022

household income from 2009 to 2013 was $53,046, according to the United States Census Bureau, but many of the most recently approved anticancer treatments approved by the United States Food and Drug Administration (FDA) are priced well above $100,000 per year. This leads to a question; “where does it end?”

Pharma 210

Pharma Food and Drug Administration Marketing Prescription 210

European Pharmaceutical Review

MAY 12, 2023

Innovative therapies for rare diseases The acquisition will help to drive the growth of CTI’s lead product, kinase inhibitor VONJO ® (pacritinib) “in treating myeloproliferative disease,” stated Dr Adam Craig, President, Chief Executive Officer and Interim Chief Medical Officer of CTI BioPharma.

Food and Drug Administration 105

Food and Drug Administration Biopharma Medicine Food 105

Evolve Your Success

OCTOBER 16, 2024

Meet the guest: Marie Robert, Anesthesia sales specialist at GE Healthcare the leading vendor for anesthesia. Connect with her: LinkedIn Best Food – Casa Della Mozzarella ( [link] ) Watch the episode here: Or Listen to it on your favorite platform: Spotify I Apple Podcasts Love the show?

Sales 130

Sales Medical sales Competition Sales experience 130

Pharmaceutical Technology

OCTOBER 7, 2022

Provention Bio and Sanofi US have signed a co-promotion agreement to launch the former’s lead investigational drug candidate, teplizumab for the delay in the onset of clinical type 1 diabetes (T1D). The US Food and Drug Administration (FDA) is presently reviewing teplizumab for the delay of clinical T1D in people who are at risk.

Food and Drug Administration 119

Food and Drug Administration FDA Healthcare Provider Prospecting 119

European Pharmaceutical Review

DECEMBER 5, 2023

Incretins are “gut hormones that are secreted after food intake and play a role in modulating blood glucose by stimulating insulin secretion and suppressing appetite,” Roche highlighted. Roche has agreed to acquire biotech Carmot Therapeutics for an upfront purchase price of $2.7

Food 110

Food Leads Pharma Patients 110

European Pharmaceutical Review

MARCH 27, 2025

According to the findings, nearly 90 percent of US biotechs rely on imported components for at least half of their products approved by the US Food and Drug Administration. This makes supply of medicines vulnerable especially to proposed tariffs on the EU, China, and Canada, according to BIO.

Medicine 52

Medicine Food and Drug Administration Manufacturing Food 52

Pharmaceutical Technology

JUNE 6, 2023

The therapy has also received orphan drug designation and breakthrough therapy designation from the US Food and Drug Administration. Vertex Pharmaceuticals founder and newly arrived executive chair of Alkeus Joshua Boger stated: “Stargardt is a progressive, debilitating disease that leads inevitably to devastating vision loss.

Food and Drug Administration 111

Food and Drug Administration Food Pharmaceutical Medicine 111

Evolve Your Success

FEBRUARY 28, 2023

Also, if you’re reading this episode, whether you’re trying to break in, already or a medical sales professional, or you’re leading the way, you’re going to learn something that you probably haven’t heard before. I then got a chance to lead at the director level. — Sam, how are you doing?

Sales 227

Sales Medical sales Medical Physicians 227

Clarivate

MARCH 17, 2022

While we’re pleased to celebrate these scientists leading the way in sustainability research, these spotlights are not meant to be comprehensive lists of all Highly Cited Researchers contributing to a given SDG; there are many other Highly Cited Researchers that have also contributed to these SDGs, not named here. SDG 1: No Poverty.

Food 98

Food Engineering Specialization Education 98

Pharmaceutical Technology

JUNE 8, 2023

The US Food Drug Administration (FDA) has granted orphan drug designation to DTx Pharma’s investigational DTx-1252 for the treatment of Charcot-Marie-Tooth disease Type 1A (CMT1A). CMT1A is a progressive neuromuscular autosomal-dominant disease that leads to life-long loss of muscle function, as well as disability.

Food and Drug Administration 98

Food and Drug Administration FDA Food Manufacturing 98

pharmaphorum

JULY 4, 2022

Two weeks after reporting disappointing results for its lead coeliac disease therapy, 9 Meters Biopharma will draw some comfort from a mid-stage trial of its candidate for short bowel syndrome (SBS), although its share price remains under pressure. Some children are born with an abnormally short small intestine.

Leads 98

Leads Biopharma Food Safety 98

European Pharmaceutical Review

NOVEMBER 27, 2023

This leads to a lipid build-up in vital organs such as the liver, blood vessels and other tissues, and is usually fatal for these individuals within their first twelve months of life, Alexion reported. This ultra-rare metabolic disease occurs due to lysosomal acid lipase (LAL) enzyme deficiency.

Food and Drug Administration 105

Food and Drug Administration Consulting Food Medicine 105

Pharmaceutical Technology

APRIL 3, 2023

With eight marketed biosimilars, Sandoz is offering the broadest biosimilar portfolio and is the leading biosimilars company in Europe, with more than two decades of experience. The citrate-free HCF of Hyrimoz (adalimumab-adaz) injection has also recently received approval from the US Food and Drug Administration (FDA).

Marketing 105

Marketing Food and Drug Administration Medicine Food 105

European Pharmaceutical Review

OCTOBER 24, 2023

PENBRAYA (meningococcal groups A, B, C, W and Y vaccine), the first and only pentavalent vaccine that provides the broadest serogroup coverage of any meningococcal vaccine available in the US for meningococcal disease in individuals aged 10 to 25 years old, has been approved by the US Food and Drug Administration (FDA). About PENBRAYA?

Food and Drug Administration 105

Food and Drug Administration Safety Food FDA 105

Integrity Solutions

AUGUST 28, 2019

Our research with The Sales Management Association uncovered what leading companies do that drives up to 20% greater sales performance. And they are sure to leave you with plenty of food for thought about what you can do to give all your salespeople the tools they need to reach their full selling potential in 2019, 2020 and beyond.

Training 45

Training Sales Sales Management Management 45

European Pharmaceutical Review

DECEMBER 5, 2023

Currently, imetelstat is being reviewed by the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) for approval in transfusion dependent anaemia in patients with lower risk MDS who have failed to respond or have lost response to or are ineligible for ESAs, according to Geron.

Food and Drug Administration 115

Food and Drug Administration Patients Food Medicine 115

European Pharmaceutical Review

NOVEMBER 28, 2023

The US Food and Drug Administration (FDA) has approved the first drug for desmoid tumours (desmoid fibromatosis), an oral gamma secretase inhibitor. SpringWorks Therapeutics’ Ogsiveo (nirogacestat) tablets are authorised for adults with progressing desmoid tumours who require systemic treatment.

Food and Drug Administration 104

Food and Drug Administration Medicine FDA Food 104

Pharmaceutical Technology

APRIL 18, 2023

IntelGenx Corp announced that the US Food and Drug Administration (FDA) has approved the company’s Rizafilm VersaFilm new drug application (NDA) for the treatment of acute migraine. The drug constricts blood vessels leading to a reduction in swelling and inflammation of blood vessels associated with migraine.

Food and Drug Administration 98

Food and Drug Administration FDA Food Marketing 98

Pharmaceutical Technology

JANUARY 19, 2023

The US Food and Drug Administration (FDA) has granted Fast Track designation for Avidity Biosciences’ AOC 1020 to treat facioscapulohumeral muscular dystrophy (FSHD). This DUX4 protein abnormal expression leads to modifications in gene expression in muscle cells which are associated with progressive muscle function loss in FSHD patients.

Food and Drug Administration 98

Food and Drug Administration FDA Food Safety 98

Pharmaceutical Technology

SEPTEMBER 6, 2022

The US Food and Drug Administration (FDA) has awarded Orphan Drug Designation (ODD) to Avacta Group’s lead pre|CISION drug candidate, AVA6000, to treat soft tissue sarcoma. Updated using the pre|CISION technology, AVA6000 is a kind of generic chemotherapy doxorubicin.

Food and Drug Administration 98

Food and Drug Administration FDA Safety Food 98

European Pharmaceutical Review

FEBRUARY 21, 2023

SYFOVRE (pegcetacoplan injection) is the first and only treatment approved by the US Food and Drug Administration (FDA) for geographic atrophy (GA), a leading cause of blindness. GA is an advanced form of age-related macular degeneration (AMD).

FDA 98

FDA Food and Drug Administration Food Leads 98

European Pharmaceutical Review

APRIL 10, 2025

These chemicals are everywhere and have been used in many ways over the decades, bringing a range of benefits from water- and stain-resistant coatings and firefighting foams to nail polish and food packaging. However, the world is now learning they are also persistent pollutants that contaminate our soil, water and air.

Pharmaceutical manufacturing 59

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharmaceutical products 59

Pharmaceutical Technology

NOVEMBER 23, 2022

The US Food and Drug Administration (FDA) has granted approval for CSL Behring’s adeno-associated virus vector-based gene therapy, Hemgenix (etranacogene dezaparvovec), to treat haemophilia B (congenital Factor IX deficiency) in adult patients. at six months and 24 months, respectively, following infusion.

Food and Drug Administration 105

Food and Drug Administration FDA Side effects Food 105

European Pharmaceutical Review

SEPTEMBER 8, 2023

Tirzepatide has been shown… [to lead] to substantial weight loss of, on average, 15 percent over 70 weeks. The US Food and Drug Administration (FDA) first approved tirzepatide for type 2 diabetes in May 2022. Final guidance is scheduled to be published on 11 October 2023.

Food and Drug Administration 105

Food and Drug Administration Medicine Food Manufacturing 105

pharmaphorum

NOVEMBER 2, 2022

This leads to psychological harm becoming a significant factor in chronic pain, alongside the physical symptoms. At the beginning of this year , the US Food and Drug Administration (FDA) issued draft guidance to provide recommendations to companies developing non-addictive alternatives to opioids. The potential for a digital solution.

Food and Drug Administration 135

Food and Drug Administration Food Patients FDA 135

European Pharmaceutical Review

JUNE 11, 2023

The US Food and Drug Administration (FDA) has approved commercial production at Bristol Myers Squibb’s newest cell therapy manufacturing facility in Devens, Massachusetts. The 244,000 square foot facility in Devens is BMS’ third commercial cell therapy facility in the US. The Devens facility is expected to create 500 new cell therapy jobs.

Manufacturing 105

Manufacturing Food and Drug Administration FDA Engineering 105

European Pharmaceutical Review

JANUARY 5, 2024

These results should lead to expediting the conduct of a placebo-controlled international trial to replicate these results,” Professor John Kane, Professor of Psychiatry and Molecular Medicine, The Donald and Barbara Zucker School of Medicine, Hempstead New York noted.

Food and Drug Administration 111

Food and Drug Administration Medical Safety Patients 111

Healthcare Success

OCTOBER 30, 2024

Find out in our latest podcast featuring Danielle Wiley, CEO of Sway Group, a leading influencer marketing agency. You see them a lot in the food world just because people Google to find recipes. And so then you find a food blog. That was the first niche or vertical to really start getting paid for sponsored content. I'll do it.

Marketing 108

Marketing Healthcare Healthcare Recruitment 108